The Evolution of Mpox: The Shift Toward Clade I
Although many remember the initial 2022 outbreak driven by clade II, the landscape of mpox is shifting. Public health data indicates that while clade II remains occasionally detectable in wastewater—particularly in the Bay Area—a more severe strain, known as clade I, is emerging as a primary concern for health officials.
Recent reports have confirmed the arrival of this more deadly strain in the United States, with California reporting the first known U.S. Cases. This transition marks a critical turning point in how the virus is monitored and managed globally.
Changing Transmission Dynamics
The way mpox spreads is evolving. In Central and Eastern African countries, clade I initially spread through heterosexual intimate contact and within households, affecting both adults and children. However, a fresh trend has emerged in Central Western European countries.
Health agencies have noted cases among individuals with no documented history of international travel. The CDC concludes these cases are likely related to intimate or sexual exposure among men who have sex with men (MSM). This suggests that clade I is moving beyond travel-related infections and into community spread within the U.S. And Europe.
New Frontiers in Detection and Diagnosis
As the virus evolves, the methods for detecting it are expanding. While traditional healthcare providers remain the primary point of contact, other professionals are now playing a role in early detection.
For example, the California Dental Association (CDA) has highlighted that dentists can help detect mpox during routine patient examinations, as rashes or sores can appear inside the mouth. This expanded surveillance is vital for catching cases that might otherwise be overlooked.
wastewater monitoring continues to be a powerful tool. By tracking viral fragments in sewage, cities can detect the presence of mpox in a population even before individuals seek medical care, providing an early warning system for potential spikes in cases.
Navigating Vaccination in a Changing Landscape
Vaccination remains the most effective defense against both clade I and clade II. The Jynneos vaccine, a two-dose series, provides the best protection. To achieve maximal immunity, the second dose must be administered roughly a month after the first, with full protection building two weeks after the final shot.
Who Should Prioritize Vaccination?
Current recommendations target high-risk groups to prevent community transmission. The CDC recommends the vaccine for:
- Gay, bisexual, and other men who have sex with men, as well as transgender, nonbinary, or gender-diverse people who have had more than one sexual partner or a new STI diagnosis in the last six months.
- Individuals who have visited commercial sex venues, such as bathhouses or sex clubs.
- People living with HIV, sex workers, and those taking or eligible for PrEP.
- Travelers heading to countries with active clade I outbreaks, especially if they anticipate high-risk sexual encounters.
While originally for adults, the FDA has issued emergency-use authorization allowing the vaccine for those under 18 who are determined to be at high risk.
Accessing the Vaccine
Navigating the cost and location of vaccines can be complex. While the vaccine itself is free, the venue matters:
- Primary Care Providers: Often the best first step, though a standard office copay may apply.
- Public Health Clinics: SFDPH recommends their clinics for those without insurance or a regular provider.
- Pharmacies: Options like CVS or Walgreens are available, but It’s crucial to verify insurance coverage beforehand to avoid steep out-of-pocket costs.
Mpox Frequently Asked Questions
What is the difference between clade I and clade II?
Clade I is generally considered a more severe and deadly strain of the virus compared to clade II, which was more prevalent during the 2022 global outbreak.
How does mpox spread?
It spreads through close, skin-to-skin contact, including intimate contact (kissing, cuddling, sex), direct contact with infectious rashes or scabs, and contact with contaminated bodily fluids or items.
Does the current vaccine work for the new strain?
Yes, the Jynneos vaccine is stated to protect against both clade I and clade II.
Will getting the vaccine affect my immigration status?
No. Receiving an mpox vaccine does not make you a public charge and does not affect future immigration processes.
Stay Informed: To find a vaccine site near you, visit myturn.ca.gov or check the SFDPH vaccine list.
Join the Conversation: Have you updated your health screenings or vaccination status recently? Share your questions or experiences in the comments below, or subscribe to our newsletter for the latest public health updates.
